Literature DB >> 12468460

Drug eluting coronary stents.

N P Jenkins, B D Prendergast, M Thomas.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12468460      PMCID： PMC1124789          DOI： 10.1136/bmj.325.7376.1315

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

Authors:  A M Lincoff; R M Califf; D J Moliterno; S G Ellis; J Ducas; J H Kramer; N S Kleiman; E A Cohen; J E Booth; S K Sapp; C F Cabot; E J Topol
Journal:  N Engl J Med       Date:  1999-07-29       Impact factor: 91.245

2.  Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT).

Authors:  A E Raizner; S N Oesterle; R Waksman; P W Serruys; A Colombo; Y L Lim; A C Yeung; W J van der Giessen; L Vandertie; J K Chiu; L R White; P J Fitzgerald; G L Kaluza; N M Ali
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

Review 3.  Dealing with in-stent restenosis.

Authors:  A H Gershlick; J Baron
Journal:  Heart       Date:  1998-04       Impact factor: 5.994

4.  Catheter-based radiotherapy to inhibit restenosis after coronary stenting.

Authors:  P S Teirstein; V Massullo; S Jani; J J Popma; G S Mintz; R J Russo; R A Schatz; E M Guarneri; S Steuterman; N B Morris; M B Leon; P Tripuraneni
Journal:  N Engl J Med       Date:  1997-06-12       Impact factor: 91.245

5.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.

Authors:  P W Serruys; P de Jaegere; F Kiemeneij; C Macaya; W Rutsch; G Heyndrickx; H Emanuelsson; J Marco; V Legrand; P Materne
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

6.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245
  6 in total
  2 in total

1.  Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study.

Authors:  A Bagust; A D Grayson; N D Palmer; R A Perry; T Walley
Journal:  Heart       Date:  2005-04-14       Impact factor: 5.994

2.  A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.

Authors:  M Lourdes Sampietro; Stella Trompet; Jeffrey J W Verschuren; Rudolf P Talens; Joris Deelen; Bastiaan T Heijmans; Robbert J de Winter; Rene A Tio; Pieter A F M Doevendans; Santhi K Ganesh; Elizabeth G Nabel; Harm-Jan Westra; Lude Franke; Erik B van den Akker; Rudi G J Westendorp; Aeilko H Zwinderman; Adnan Kastrati; Werner Koch; P Eline Slagboom; Peter de Knijff; J Wouter Jukema
Journal:  Hum Mol Genet       Date:  2011-08-30       Impact factor: 6.150
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.